These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 32768648)
1. Optimization of globomycin analogs as novel gram-negative antibiotics. Garland K; Pantua H; Braun MG; Burdick DJ; Castanedo GM; Chen YC; Cheng YX; Cheong J; Daniels B; Deshmukh G; Fu Y; Gibbons P; Gloor SL; Hua R; Labadie S; Liu X; Pastor R; Stivala C; Xu M; Xu Y; Zheng H; Kapadia SB; Hanan EJ Bioorg Med Chem Lett; 2020 Oct; 30(20):127419. PubMed ID: 32768648 [TBL] [Abstract][Full Text] [Related]
2. Unstable Mechanisms of Resistance to Inhibitors of Escherichia coli Lipoprotein Signal Peptidase. Pantua H; Skippington E; Braun MG; Noland CL; Diao J; Peng Y; Gloor SL; Yan D; Kang J; Katakam AK; Reeder J; Castanedo GM; Garland K; Komuves L; Sagolla M; Austin CD; Murray J; Xu Y; Modrusan Z; Xu M; Hanan EJ; Kapadia SB mBio; 2020 Sep; 11(5):. PubMed ID: 32900806 [TBL] [Abstract][Full Text] [Related]
3. Computational Design of Cyclic Peptide Inhibitors of a Bacterial Membrane Lipoprotein Peptidase. Craven TW; Nolan MD; Bailey J; Olatunji S; Bann SJ; Bowen K; Ostrovitsa N; Da Costa TM; Ballantine RD; Weichert D; Levine PM; Stewart LJ; Bhardwaj G; Geoghegan JA; Cochrane SA; Scanlan EM; Caffrey M; Baker D ACS Chem Biol; 2024 May; 19(5):1125-1130. PubMed ID: 38712757 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and antimicrobial activity of novel globomycin analogues. Kiho T; Nakayama M; Yasuda K; Miyakoshi S; Inukai M; Kogen H Bioorg Med Chem Lett; 2003 Jul; 13(14):2315-8. PubMed ID: 12824025 [TBL] [Abstract][Full Text] [Related]
5. Structure-activity relationships of globomycin analogues as antibiotics. Kiho T; Nakayama M; Yasuda K; Miyakoshi S; Inukai M; Kogen H Bioorg Med Chem; 2004 Jan; 12(2):337-61. PubMed ID: 14723954 [TBL] [Abstract][Full Text] [Related]
6. Ebselen bearing polar functionality: Identification of potent antibacterial agents against multidrug-resistant Gram-negative bacteria. Chen C; Yang K Bioorg Chem; 2019 Dec; 93():103286. PubMed ID: 31585265 [TBL] [Abstract][Full Text] [Related]
7. Facilitating Compound Entry as a Means to Discover Antibiotics for Gram-Negative Bacteria. Muñoz KA; Hergenrother PJ Acc Chem Res; 2021 Mar; 54(6):1322-1333. PubMed ID: 33635073 [TBL] [Abstract][Full Text] [Related]
8. Design, Synthesis, and Evaluation of Amphiphilic Cyclic and Linear Peptides Composed of Hydrophobic and Positively-Charged Amino Acids as Antibacterial Agents. Riahifard N; Mozaffari S; Aldakhil T; Nunez F; Alshammari Q; Alshammari S; Yamaki J; Parang K; Tiwari RK Molecules; 2018 Oct; 23(10):. PubMed ID: 30360400 [TBL] [Abstract][Full Text] [Related]
9. Myxobacterium-produced antibiotic TA (myxovirescin) inhibits type II signal peptidase. Xiao Y; Gerth K; Müller R; Wall D Antimicrob Agents Chemother; 2012 Apr; 56(4):2014-21. PubMed ID: 22232277 [TBL] [Abstract][Full Text] [Related]
10. Deletion of a previously uncharacterized lipoprotein lirL confers resistance to an inhibitor of type II signal peptidase in Huang KJ; Pantua H; Diao J; Skippington E; Volny M; Sandoval W; Tiku V; Peng Y; Sagolla M; Yan D; Kang J; Katakam AK; Michaelian N; Reichelt M; Tan MW; Austin CD; Xu M; Hanan E; Kapadia SB Proc Natl Acad Sci U S A; 2022 Sep; 119(38):e2123117119. PubMed ID: 36099298 [No Abstract] [Full Text] [Related]
11. LspA-independent action of globomycin on Mycobacterium tuberculosis. Banaiee N; Jacobs WR; Ernst JD J Antimicrob Chemother; 2007 Aug; 60(2):414-6. PubMed ID: 17579235 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and antibacterial evaluation of novel cationic chalcone derivatives possessing broad spectrum antibacterial activity. Chu WC; Bai PY; Yang ZQ; Cui DY; Hua YG; Yang Y; Yang QQ; Zhang E; Qin S Eur J Med Chem; 2018 Jan; 143():905-921. PubMed ID: 29227931 [TBL] [Abstract][Full Text] [Related]
13. Microwave-assisted solid-phase synthesis of antisense acpP peptide nucleic acid-peptide conjugates active against colistin- and tigecycline-resistant E. coli and K. pneumoniae. Hansen AM; Bonke G; Hogendorf WFJ; Björkling F; Nielsen J; Kongstad KT; Zabicka D; Tomczak M; Urbas M; Nielsen PE; Franzyk H Eur J Med Chem; 2019 Apr; 168():134-145. PubMed ID: 30807888 [TBL] [Abstract][Full Text] [Related]
14. Discovery of dual GyrB/ParE inhibitors active against Gram-negative bacteria. Ho SY; Wang W; Ng FM; Wong YX; Poh ZY; Tan SWE; Ang SH; Liew SS; Joyner Wong YS; Tan Y; Poulsen A; Pendharkar V; Sangthongpitag K; Manchester J; Basarab G; Hill J; Keller TH; Cherian J Eur J Med Chem; 2018 Sep; 157():610-621. PubMed ID: 30125722 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and antibacterial evaluation against resistant Gram-negative bacteria of monobactams bearing various substituents on oxime residue. Li ZW; Lu X; Wang YX; Hu XX; Fu HG; Gao LM; You XF; Tang S; Song DQ Bioorg Chem; 2020 Jan; 94():103487. PubMed ID: 31831161 [TBL] [Abstract][Full Text] [Related]
16. Stringency of bacterial prolipoprotein signal peptidase (LspA) in recognition of signal peptides - Structure-function correlation. Sangith N; Sankaran K Biochem Biophys Res Commun; 2017 Jun; 488(2):413-417. PubMed ID: 28506828 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and antibacterial activity of peptide deformylase inhibitors. Huntington KM; Yi T; Wei Y; Pei D Biochemistry; 2000 Apr; 39(15):4543-51. PubMed ID: 10758004 [TBL] [Abstract][Full Text] [Related]
18. A Convenient Chemoenzymatic Preparation of Chimeric Macrocyclic Peptide Antibiotics with Potent Activity against Gram-Negative Pathogens. Wood TM; Slingerland CJ; Martin NI J Med Chem; 2021 Aug; 64(15):10890-10899. PubMed ID: 34283589 [TBL] [Abstract][Full Text] [Related]
19. Structural basis of lipoprotein signal peptidase II action and inhibition by the antibiotic globomycin. Vogeley L; El Arnaout T; Bailey J; Stansfeld PJ; Boland C; Caffrey M Science; 2016 Feb; 351(6275):876-80. PubMed ID: 26912896 [TBL] [Abstract][Full Text] [Related]
20. Compound design guidelines for evading the efflux and permeation barriers of Escherichia coli with the oxazolidinone class of antibacterials: Test case for a general approach to improving whole cell Gram-negative activity. Spaulding A; Takrouri K; Mahalingam P; Cleary DC; Cooper HD; Zucchi P; Tear W; Koleva B; Beuning PJ; Hirsch EB; Aggen JB Bioorg Med Chem Lett; 2017 Dec; 27(23):5310-5321. PubMed ID: 29102393 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]